Isomorphic Labs Receives Option to Co-Fund Development for Higher Royalties
Merck and Isomorphic Labs announced an option for Isomorphic to co-fund development in exchange for elevated royalties.
Merck and Isomorphic Labs announced an option for Isomorphic to co-fund development in exchange for elevated royalties.